Best Blue Chip Stocks To Watch Right Now

tags:CLDX,AON,BCRH,NC,PNC,

Shutterstock

Don��t take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

It��s dangerous to buy headline yields �� or even supposedly ��safe�� blue chips with more modest dividends �� without looking at the profits funding these payouts. Companies with high payout ratios (how much in earnings, funds from operations and other measures a company pays out in the form of dividends) are a twofold risk:

High payout ratios can lead to a slowing in dividend growth, which means your payout is increasingly likely to fall behind inflation.

Best Blue Chip Stocks To Watch Right Now: Celldex Therapeutics Inc(CLDX)

Advisors' Opinion:

• [By Keith Speights]

  Most of the time, quarterly financial results are important for companies. Investors eagerly await the update on revenue and earnings. But for Celldex Therapeutics (NASDAQ:CLDX), it's a different story.�

• [By Cory Renauer]

  April's been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ:INCY), Prothena Corporation PLC (NASDAQ:PRTA), and Celldex Therapeutics Inc. (NASDAQ:CLDX)�have all reported clinical trial failures that have hammered their�stock prices.

• [By Paul Ausick]

  Celldex Therapeutics Inc. (NASDAQ: CLDX) fell by about 7.6% Wednesday to post a new 52-week low of $0.72 after closing at $0.79 on Tuesday. The 52-week high is $3.42. Volume of about 9 million was more than four times the daily average of about 2 million. The company continues to get beaten up following a failed breast cancer drug study.

• [By Paul Ausick]

  Celldex Therapeutics Inc. (NASDAQ: CLDX) traded down nearly 65% Monday to post a new 52-week low of $0.76 after closing Friday at $2.15. The stock’s 52-week high is $3.42. Volume was about 25 times the daily average of around 1.4 million shares. The company’s breast cancer drug failed to meet a phase 2 study’s primary endpoint.

Best Blue Chip Stocks To Watch Right Now: Aon Corporation(AON)

Advisors' Opinion:

• [By Lisa Levin] Companies Reporting Before The Bell Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion. Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion. American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion. Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion. LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion. V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion. Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion. Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million. Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion. Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion. Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million. ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million. Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million. Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million. Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion. Genesis Energy, L.P
• [By Max Byerly]

  State of Wisconsin Investment Board decreased its holdings in shares of Aon (NYSE:AON) by 9.2% in the 1st quarter, Holdings Channel reports. The fund owned 384,127 shares of the financial services provider’s stock after selling 38,942 shares during the quarter. State of Wisconsin Investment Board’s holdings in AON were worth $53,905,000 at the end of the most recent quarter.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on AON (AON)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  AON (NYSE:AON) had its price target hoisted by Citigroup from $160.00 to $165.00 in a report issued on Tuesday morning. They currently have a buy rating on the financial services provider’s stock.

Best Blue Chip Stocks To Watch Right Now: Blue Capital Reinsurance Holdings Ltd.(BCRH)

Advisors' Opinion:

• [By Joseph Griffin]

  Here are some of the headlines that may have impacted Accern’s rankings:

  Get Akari Therapeutics alerts: Akari Therapeutics, Plc (AKTX) Analysts See $-1.00 EPS; HC INTERNATIONAL ORDINARY SHARES CA (HCINF … (mtastar.com) Trader’s Buzzers- Boxlight Corporation (NASDAQ:BOXL), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH), Akari … (journalfinance.net) Akari Therapeutics (AKTX) Lifted to “Hold” at ValuEngine (americanbankingnews.com) Guillain-Barre Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMRGlobal Guillain��Barre Syndrome … (markets.businessinsider.com) Analysts See $-1.00 EPS for Akari Therapeutics, Plc (AKTX); Verastem (VSTM) SI Decreased By 7.78% (mtastar.com)

  Several brokerages have commented on AKTX. ValuEngine upgraded Akari Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity cut their target price on Akari Therapeutics from $15.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, March 29th. B. Riley began coverage on Akari Therapeutics in a research note on Thursday, February 8th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Zacks Investment Research downgraded Akari Therapeutics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $4.63.

• [By Shane Hupp]

  Blue Capital Reinsurance (NYSE:BCRH) reached a new 52-week high and low during trading on Thursday . The company traded as low as $10.90 and last traded at $11.05, with a volume of 17133 shares trading hands. The stock had previously closed at $11.20.

Best Blue Chip Stocks To Watch Right Now: New Century Bancorp Inc.(NC)

Advisors' Opinion:

• [By Stephan Byrd]

  Whirlpool (NYSE: WHR) and NACCO Industries (NYSE:NC) are both consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Best Blue Chip Stocks To Watch Right Now: PNC Financial Services Group, Inc. (PNC)

Advisors' Opinion:

• [By Garrett Baldwin]
  Earnings season will kick into high gear today with the release of multiple reports from three of the nation's top financial institutions. JPMorgan Chase & Co. (NYSE: JPM), Wells Fargo & Co.�(NYSE: WFC), and Citigroup Inc. (NYSE: C) will all be in the spotlight today. U.S. President Donald Trump could be shaking up trade policy. However, it isn't NAFTA or tariffs with China that are headlining the story. According to reports, Trump has requested his advisors explore American reentry into the Transpacific Partnership (TPP). President Trump pulled the United States out of TPP shortly following his inauguration. The recommendation comes after lawmakers from ag-producing states discussed the impact of leaving the deal with the administration. The decision to reenter the TPP would be very valuable to states that produce the bulk of U.S. wheat given that it would allow exporters to avoid tariffs of $65 per tonne to Japan, which is the largest export market for American wheat. Leading nations of the pact, such as Japan and Australia, reacted coolly to the president's pivot but did not rule out the possibility of American reentry. Facebook Inc. (Nasdaq: FB) is still in focus across the financial world. Facebook CEO Mark Zuckerberg appeared before Congress two times this week to address his firm's ongoing data scandal involving consulting firm Cambridge Analytica. Congress' failure to understand how the Internet works and Facebook's business model was on full display, but Zuckerberg was able to maintain his composure as he answered questions over the two-day period. Stocks to Watch Today: JPM, WFC, C Shares of JPMorgan Chase & Co. (NYSE: JPM) are in focus as the bank prepares to report Q1 earnings before the bell. JPM stock added 1.1% despite falling short of profit expectations. Wall Street anticipated that the firm would report earnings per share (EPS) of $2.28 on top of $27.53 billion in revenue. The firm reported EPS of $2.26; however, it reported
• [By John Maxfield]

  Over the past two decades, PNC Financial Services Group (NYSE:PNC) has�evolved into one of the best-managed companies in the financial services sector.

• [By Shah Gilani]

  It doesn't matter that other banks like JPMorgan Chase & Co. (NYSE: JPM), Bank of America Corp. (NYSE: BAC), and The PNC Financial Services Group Inc. (NYSE: PNC) don't force-place insurance on their auto loan customers.

• [By Joseph Griffin]

  Pendal Group Ltd increased its stake in PNC Financial Services (NYSE:PNC) by 70.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,051 shares of the financial services provider’s stock after acquiring an additional 47,363 shares during the period. Pendal Group Ltd’s holdings in PNC Financial Services were worth $17,400,000 at the end of the most recent reporting period.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was The PNC Financial Services Group, Inc. (NYSE: PNC) which traded down about 4% at $145.63. The stock��s 52-week range is $115.45 to $163.59. Volume was over 4 million compared to the daily average volume of 2.3 million.

• [By Chris Lange]

  PNC Financial Services Group Inc. (NYSE: PNC) also is set to release its most recent quarterly results Friday morning. The consensus forecast calls for $2.28 in EPS on $4.18 billion in revenue. Shares ended last week at $144.78. The consensus price target is $150.00, and the 52-week range is $113.66 to $147.28.